Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Caffeine (200 mg) NCT07022496 · Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine At… | Migraine | À vérifier | Phase 4 | RECRUITING | Caffeine extracted from green tea to abort acute attack of Migraine À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| HELP-VM — Healthy Living Partnerships for Veterans With Migraine NCT04373330 · NCT04373330 | Migraine | Traitement symptomatique | Non applicable | WITHDRAWN | This pilot study, modeled upon the successful and empirically validated HE… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Partial Rebreathing Device NCT05546385 · PAREMA1 — PArtial REbreathing for Migraine With Aura 1 | Migraine | À vérifier | Non applicable | TERMINATED | A prospective, multi-centre, randomized, double-blind, sham-controlled, pa… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Active drug for chronic migraine treatment. NCT07071506 · New Methods for Evaluating Preventive Migraine Treatment | Migraine | À vérifier | Non applicable | RECRUITING | The study aims to test interactions between drug and placebo-responses in… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Actual device PFO closure NCT04100135 · RELIEF — GORE® CARDIOFORM Septal Occluder Migraine Clinical Study | Migraine | À vérifier | Non applicable | TERMINATED | Multi-center, prospective, randomized, placebo- and sham-controlled study… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients NCT04157192 · NCT04157192 | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Acupuncture has been a means of treating headaches and migraine since 2002… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACUPMIGRAINE — The Impact of Acupuncture on Biomarkers of Brain Injur… NCT07292506 · NCT07292506 | Migraine | Immunomodulation · Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | Migraine is more than just a headache-it can involve changes in the brain… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Amiloride NCT04063540 · APAM — Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on t… | Migraine | À vérifier | Phase 2 | RECRUITING | Recent data suggest involvement of Acid-Sensing Ion Channel channels in th… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| App-Based Migraine Treatment: The Health enSuite Study NCT06797076 · NCT06797076 | Migraine | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | Health enSuite is a suite of applications designed by our research team at… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Atogepant 60 mg NCT06414044 · STAR — Italian Real-life obServational Study on the effecTiveness, sAfety and To… | Migraine | À vérifier | À vérifier | ACTIVE_NOT_RECRUITING | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| BE WELL With Migraine: Brain Education and WELLness With Migraine NCT05987592 · NCT05987592 | Migraine | À vérifier | Non applicable | RECRUITING | The goal of this randomized clinical trial is to evaluate two different no… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Biodegradable occluder NCT06203873 · BioMetal — A Comparison of Biodegradable and Metal Occluders in Patients With PF… | Migraine | Traitement symptomatique | Non applicable | RECRUITING | Migraine is one of the most common chronic neurological disorders, posing… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Calcitonin-gene related peptide (CGRP) NCT07021859 · Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | Migraine | À vérifier | Non applicable | RECRUITING | Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Clorazepate Dipotassium NCT04726592 · CLORMIG — Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Em… | Migraine | À vérifier | Phase 3 | TERMINATED | The purpose of this study is to evaluate the efficacy of clorazepate in ad… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Exploring the Effect of the Transcendental Meditation® Technique on M… NCT06695156 · NCT06695156 | Migraine | À vérifier | Non applicable | COMPLETED | This research will explore the effect of the Transcendental Meditation® Te… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Levcromakalim NCT04853797 · Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migra… | Migraine | Traitement symptomatique | Non applicable | COMPLETED | This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Mi-Helper NCT06874361 · CALM3 — Cooling to Alleviate Migraine #3 | Migraine | À vérifier | Non applicable | COMPLETED | This is a prospective, double-blind, sham-controlled, randomized, decentra… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| MTX101 NCT06728553 · Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in A… | Migraine | Traitement symptomatique · Thérapie génique | Phase 2 | COMPLETED | The goal of this clinical trial is to learn if drug MTX101 works to treat… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Nerivio device NCT06023953 · Migraine With and Without Aura Characteristics and Response to Remote Electrical… | Migraine | Traitement symptomatique | À vérifier | COMPLETED | This is a Post-marketing, real-world evidence study investigating the safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Neuromodulation Wearable Device NCT07642414 · A Comprehensive Digital Care Program for Migraine Management | Migraine | À vérifier | Non applicable | RECRUITING | This study evaluates the clinical effectiveness of the Enso for Migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Children exposed to hydroxychloroquine in utero show no signs of reti… Ocular Coherence Tomography (OCT) · PMID 42203251 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Limited examinations from prior studies support the absence of retinal toxicity in infants exposed to maternal hydroxyc… | Lupus science & medicine 2026-09-14 15:36:40 | Source |
| Clinical and surgical approach to retinoschisis. Ocular Coherence Tomography (OCT) · PMID 41578616 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To summarize the recent literature on the clinical and surgical management of retinoschisis. Novel analyses of the exis… | Current opinion in ophthalmology 2026-09-14 15:36:40 | Source |
| Visual Acuity and Intraretinal Fluid as Predictive Factors for Legal… Ocular Coherence Tomography (OCT) · PMID 42088264 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Ocular coherence tomography (OCT) biomarkers have previously been able to predict low visual acuity (VA). The purpose o… | Clinical ophthalmology (Auckland, N.Z.) 2026-09-14 15:36:40 | Source |
| Investigate the differential diagnoses of recurrent benign paroxysmal… Findings Of The Video Head Impulse Test In Patients With Vestibular Migraine · PMID 41778353 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Benign paroxysmal positional vertigo (BPPV) frequently recurs, posing diagnostic challenges when distinguishing recurre… | Acta oto-laryngologica 2026-09-14 12:36:46 | Source |
| Prostatic Artery Embolization Using Ethylene Vinyl Alcohol Copolymer… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 41739171 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source This study evaluated the short-term efficacy and safety of prostatic artery embolization (PAE) using ethylene vinyl alc… | Cardiovascular and interventional radiology 2026-09-14 12:36:46 | Source |
| Sensitivity and specificity of the video head impulse test in the dia… Findings Of The Video Head Impulse Test In Patients With Vestibular Migraine · PMID 41931986 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source To estimate the proportion of patients with VM who have abnormal vHIT results and to determine the sensitivity and spec… | Brazilian journal of otorhinolaryngology 2026-09-14 12:36:46 | Source |
| Successful retrieval of ethylene vinyl alcohol (EVOH) from the left m… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 37350037 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Preoperative embolization of a juvenile nasopharyngeal angiofibroma (JNA) using ethyl vinyl alcohol (EVOH) is an effect… | Interventional neuroradiology : journal of peritherape… 2026-09-14 12:36:46 | Source |
| Safety and efficacy of newer liquid embolic agents Squid and PHIL in… liquid embolic agent SQUID 12, liquid embolic agent SQUID 18 · PMID 39569607 | Migraine | À vérifier | Publication | PubMed | Voir la publication source BackgroundA wide range of liquid embolic agents has been used in endovascular treatment (EVT) of dural arteriovenous fi… | Interventional neuroradiology : journal of peritherape… 2026-09-14 12:36:45 | Source |
| Anterior segment, static and dynamic pupillography changes in patient… Pupillography · PMID 41941919 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Glaucoma is a major cause of avoidable blindness and the most common type is primary open angle glaucoma (POAG). Topica… | Photodiagnosis and photodynamic therapy 2026-09-11 23:42:15 | Source |
| Exploratory analysis of pupillography-based machine learning for asse… Pupillography · PMID 42322958 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The pupillary light reflex (PLR) is mediated by autonomic pathways, offering a potential noninvasive biomarker for Mult… | Multiple sclerosis and related disorders 2026-09-11 23:42:15 | Source |
| OpenIrisDPI: An open-source digital dual Purkinje image eye tracker f… Pupillography · PMID 41581702 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Video-based eye trackers are widely used in vision science, psychology, clinical assessment, and neurophysiology. Many… | Journal of neuroscience methods 2026-09-11 23:42:15 | Source |
| Clinical Heterogeneity in Vestibular Migraine Diagnosed Using Bárány… Videonystagmography and Vestibular Migraine · PMID 42683798 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Vestibular migraine (VM) is a common cause of episodic vertigo with heterogeneous presentations. Some VM patients show… | Journal of clinical neurology (Seoul, Korea) 2026-09-03 16:31:53 | Source |
| Hormonal Contraception and Vestibular Disorders: A Narrative Review o… Videonystagmography and Vestibular Migraine · PMID 42261458 | Migraine | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Hormonal influences on inner ear physiology are increasingly recognized, particularly in cochlear function; however, th… | Cureus 2026-09-03 16:31:53 | Source |
| Ocular Findings During Vestibular Testing in Vestibular Migraine: Sys… Videonystagmography and Vestibular Migraine · PMID 41950055 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source ImportanceVestibular migraine (VM) is diagnosed using limited consensus-based criteria and presents with symptoms that… | Journal of otolaryngology - head & neck surgery = Le J… 2026-09-03 16:31:53 | Source |
| Interaction of magnolol with bovine serum albumin: a fluorescence-que… Elismetrep (K-304) 5 mg · PMID 12830359 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The interaction of magnolol with bovine serum albumin(BSA) was studied using fluorescence spectroscopy under physiologi… | Analytical and bioanalytical chemistry 2026-09-01 09:22:47 | Source |
| Associative charge transfer reactions. Temperature effects and mechan… Elismetrep (K-304) 10 mg · PMID 16821845 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source In associative charge transfer (ACT) reactions, a core ion activates ligand molecules by partial charge transfer. The a… | The journal of physical chemistry. A 2026-09-01 09:22:45 | Source |
| Binding of dihydromyricetin to human hemoglobin: fluorescence and cir… Elismetrep (K-304) 10 mg · PMID 22465778 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The binding reaction between dihydromyricetin (DMY) and human hemoglobin (HHb) was investigated systematically with var… | Spectrochimica acta. Part A, Molecular and biomolecula… 2026-09-01 09:22:45 | Source |
| Thermodynamics, conformation and active sites of the binding of Zn-Nd… Elismetrep (K-304) 10 mg · PMID 18937061 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The interactions between N,N'-di(2-hydroxy-3-methyoxy-phenyl-1-methylene)-o-phenyldiamine-mone Zn(II), Nd(III) nitrate… | Journal of fluorescence 2026-09-01 09:22:45 | Source |
| Bergapten Attenuates Nitroglycerin-Induced Migraine Headaches through… Sumatriptan 50 mg · PMID 34455773 | Migraine | Neuroprotection · Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source The present study intended to examine the effect of bergapten and possible mechanisms involved in the treatment of migr… | ACS chemical neuroscience 2026-08-16 21:22:02 | Source |
| Onset of action in placebo-controlled migraine attacks trials: A lite… Sumatriptan 50 mg · PMID 32903063 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Migraine patients want acute treatment to provide complete relief of the migraine attack within 30 minutes. Traditional… | Cephalalgia : an international journal of headache 2026-08-16 21:22:02 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |